Health Condition 1: I251- Atherosclerotic heart disease of native coronary artery
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Rotational Atherectomy: Rotational atherectomy assisted percutaneous coronary intervention in severely calcified coronary lesions
Control
Sponsors
Rhythm Heart and Critical Care
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 18 years and above who underwent percutaneous coronary intervention for severely calcified coronary artery lesions Patients treated with either rotational atherectomy or modified balloon angioplasty Availability of complete clinical procedural and outcome data Patients treated at the study center during the defined study period
Exclusion criteria
Exclusion criteria: Patients with incomplete or missing clinical procedural or outcome data Patients with prior coronary artery bypass graft surgery involving the target vessel Patients presenting with acute ST elevation myocardial infarction requiring primary percutaneous coronary intervention Patients with non calcified or mildly calcified coronary lesions Patients with concomitant severe valvular heart disease requiring intervention Patients with known bleeding disorders or contraindications to antiplatelet therapy Patients lost to follow up or without documented outcomes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Procedural success defined as successful stent delivery and expansion with residual stenosis less than 20 percent and final thrombolysis in myocardial infarction flow grade 3 without in hospital major adverse cardiac eventsTimepoint: Assessed during index procedure and during hospital stay | — |
Secondary
| Measure | Time frame |
|---|---|
| In hospital major adverse cardiac events including death myocardial infarction target vessel revascularization and stent thrombosis, Angiographic success defined as residual stenosis less than 20 percent with adequate stent expansion, Periprocedural complications including coronary perforation dissection slow flow or no reflow and arrhythmias, Fluoroscopy time contrast volume and procedural duration, Length of hospital stayTimepoint: Assessed during index procedure and during hospital stay | — |
Countries
India
Contacts
Public ContactRakhshanda Khan
Rhythm Heart and Critical Care
Outcome results
None listed